 and
occlusive disease isolated to a single mesenteric
vessel, particularly the SMA, we suggest a shared
decision-making approach between the patient and
provider to discuss revascularization as a treatment
option. Level of recommendation: Grade 2 (Weak),
Quality of Evidence: C (Low)
6. In select asymptomatic patients with severe MAOD,
we suggest a shared decision-making approach between the patient and provider to discuss revascularization
as
a
treatment
